Twitter

Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

Condition:   Brain Tumor
Intervention:   Drug: Irinotecan combination chemotherapy
Sponsor:   Seoul National University Hospital
Recruiting – verified February 2012

Link: Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents




Comments are closed.